Treatment of Myasthenia Gravis

  title={Treatment of Myasthenia Gravis},
  author={V. Kumar and H. Kaminski},
  journal={Current Neurology and Neuroscience Reports},
  • V. Kumar, H. Kaminski
  • Published 2011
  • Medicine
  • Current Neurology and Neuroscience Reports
  • Myasthenia gravis (MG) is an antibody-mediated, neuromuscular transmission disorder, which ranges in clinical manifestations of ocular myasthenia that may be visually disabling to myasthenic crisis with patients suffering life-threatening respiratory insufficiency. MG also has pathophysiologic subgroups based on presence or absence of acetylcholine receptor or muscle-specific kinase antibodies and presence of thymoma. Cholinesterase inhibitors partially improve weakness, but the vast majority… CONTINUE READING
    52 Citations
    Overview of Myasthenia Gravis
    Myasthenia gravis: Newer therapies offer sustained improvement
    • 15
    • PDF
    Treatment of Ocular Myasthenia Gravis
    • 23
    Ocular Myasthenia Gravis: Controversies and Updates
    • 31
    Maintenance immunosuppression in myasthenia gravis
    • 34
    Maintenance immunosuppression in myasthenia gravis, an update
    • 6
    Unilateral extended thoracoscopic thymectomy for nontumoral myasthenia gravis--a new standard.
    • 14


    Myasthenia gravis and pregnancy
    • 11
    Myasthenia gravis: past, present, and future.
    • 502
    • PDF
    Treatment of Myasthenia Gravis
    • 30
    Childhood myasthenia: clinical subtypes and practical management
    • 43
    • PDF
    Controversies about the treatment of myasthenia gravis.
    • L. Rowland
    • Medicine
    • Journal of neurology, neurosurgery, and psychiatry
    • 1980
    • 107
    • PDF
    Lifetime course of myasthenia gravis
    • 381
    The history of myasthenia gravis.
    • 40
    • PDF